Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.

BMC cancer - 15 Jun 2010

Kulkarni Yogesh M, Suarez Vivian, Klinke David J

Abstract excerpt

BACKGROUND: Molecularly targeted drugs inhibit aberrant signaling within oncogenic pathways. Identifying the predominant pathways at work within a tumor is a key step towards tailoring therapies to the patient. Clinical samples pose significant challenges for proteomic profiling, an attractive ap...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Protein
Share to Electrophoresis, Gel, Two-Dimensional
Share to Patient Selection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Peptide Mapping

Share to Proteomics

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source

Open in PubMed Open full text

Identifiers

PMID: 20550684
DOI: 10.1186/1471-2407-10-291
PMCID: PMC2896362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20550684-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.PMID 20550684Read ↗

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity Read ↗

Quantitative Proteomics of Breast Benign and Malignant Tumors Reveals a Malignancy SignatureSemantic proximity Read ↗

Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines.Semantic proximity Read ↗

Molecular Characterization and Landscape of Breast cancer Models from a multi-omics PerspectiveSemantic proximity Read ↗

Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.Semantic proximity Read ↗

Defining Central Themes in Breast Cancer Biology by Differential Proteomics: Conserved Regulation of Cell Spreading and Focal Adhesion KinaseSemantic proximity Read ↗

“A Proteogenomic workflow reveals distinct molecular phenotypes related to breast cancer appearance”Semantic proximity Read ↗

Integrated Proteomic, Transcriptomic, and Biological Network Analysis of Breast Carcinoma Reveals Molecular Features of Tumorigenesis and Clinical RelapseSemantic proximity Read ↗

Plasma Membrane Proteomics of Human Breast Cancer Cell Lines Identifies Potential Targets for Breast Cancer Diagnosis and TreatmentSemantic proximity Read ↗

Path to drugging functional clones of luminal breast cancers using in-depth proteomics with spatially resolved mass spectrometry guided by MALDI imagingSemantic proximity Read ↗

Proteomic Analysis Defines Kinase Taxonomies Specific for Subtypes of Breast CancerSemantic proximity Read ↗

Integrated Multi-Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal-Like Triple-Negative Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.